Objective: Diabetes Mellitus is a chronic and progressive disease that significantly impairs the workforce and economy due to its complications. This study aims to evaluate patients diagnosed with type 2 diabetes mellitus who use different oral antidiabetic medications with regard to glycemic control and diabetic complications.
Materials and Methods: This study included 200 patients who were being followed-up for a diagnosis of Type 2 DM.
Results: Of the 200 patients included in the study, 131 were on metformin monotherapy and 69 were on metformin and gliclazide combination therapy. HbA1c value of Metformin monotherapy prescribed patients was7,6%±1,5, metformin+gliclazide prescribed patients was 8,2%±1,9. There was a statistically significant difference between the two groups in terms of blood glucose levels (p<0.05). There was no significant difference between the two groups with regard to microvascular complications and body mass index.
Conclusion: Our study determined that the level of glycemic control manifested by Type 2 DM patients was suboptimal despite using different types of oral antidiabetics and that their body mass indices were high. We reached the conclusion that the present situation is linked to factors such as incorrect dietary habits, inadequate exercise and walking, failure to comply with the medical treatment suggested by the physician, and lack of awareness about the severity of the disease.
Glycemic Control, Mealtime Glucose Excursions, and Diabetic Complications in Type 2 Diabetes Mellitus
